Perivascular innervation of the superior mesenteric artery: Pathophysiological implications;Inervación perivascular de la arteria mesentérica superior: Implicaciones fisiopatológicas

Revista de Neurologia

Volumn 50, Issue 12, 2010, Pages 727-737

  Sastre, Esther ^a   Márquez Rodas, Iván ^b   Blanco Rivero, Javier ^a   Balfagón Calvo, Gloria ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Ageing; Arterial hypertension; Calcitonin gene related peptide; Diabetes; Innervation; Nitric oxide; Noradrenalin; Portal hypertension

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NITRIC OXIDE; NORADRENALIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

AGING; ARTERIAL PRESSURE; BLOOD VESSEL INNERVATION; BLOOD VESSEL TONE; DIABETES MELLITUS; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; NITRERGIC NERVE; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; REVIEW; SENSORY NERVE; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; SYMPATHETIC INNERVATION; VASCULAR DISEASE; VASODILATATION;

EID: 77954406408     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5012.2010334     Document Type: Review

References (114)

1. Rosenblum JD, Boyle CM, Schwartz LB. The mesenteric circulation. Anatomy and physiology. Surg Clin North Am 1997; 77: 289-306.
2. Guyton AC. Local control of blood flow by the tissues, and humoral regulation. In Guyton AC, Hall JE, eds. Textbook of medical physiology. 8 ed. Philadelphia: W.B. Saunders; 1991. p. 185-93.
3. Guyton AC. Dominant control of the kidneys in long-term regulation of arterial pressure and in hypertension: the integrated system for pressure control. In Guyton AC, Hall JE, eds. Textbook of medical physiology. 8 ed. Philadelphia: W.B. Saunders; 1991. p. 194-204.
4. Guyton AC. Nervous regulation of the circulation and rapid control of arterial pressure. In Guyton AC, Hall JE, eds. Textbook of medical physiology. 8 ed. Philadelphia: W.B. Saunders; 1991. p. 205-20.
5. Gourley EJ, Gering SA. The meandering mesenteric artery: a historic review and surgical implications. Dis Colon Rectum 2005; 48: 996-1000.
6. Loesch A. Perivascular nerves and vascular endothelium: recent advances. Histol Histopathol 2002; 17: 591-7. (Pubitemid 34411213)
7. Cardinali D, Dvorkin M. Sistema nervioso autónomo. In Tresguerres JAF, Aguilar E, Cachofeiro V, Cardinali D, Gil P, Lahera V, et al, eds. Fisiología humana. 2 ed. Madrid: McGraw-Hill-Interamericana; 1999. p. 142-54.
8. Donoso MV, Steiner M, Huidobro-Toro JP. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5′-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed. J Pharmacol Exp Ther 1997; 282: 691-8. (Pubitemid 27340169)
9. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001; 53: 319-56.
10. Hein L. Adrenoceptors and signal transduction in neurons. Cell Tissue Res 2006; 326: 541-51.
11. Eglème C, Godfraind T, Miller RC. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol 1984; 81: 16-8. (Pubitemid 14148308)
12. García-Sáinz JA, Vázquez-Prado J, Del Carmen-Medina L. Alpha 1-adrenoceptors: function and phosphorylation. Eur J Pharmacol 2000; 389: 1-12.
13. Enero MA, Langer SZ, Rothlin RP, Stefano FJ. Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Br J Pharmacol 1972; 44: 672-88.
14. Werstiuk ES, Lee RM. Vascular beta-adrenoceptor function in hypertension and in ageing. Can J Physiol Pharmacol 2000; 78: 433-52.
15. Akimoto Y, Horinouchi T, Shibano M, Matsushita M, Yamashita Y, Okamoto T, et al. Nitric oxide (NO) primarily accounts for endothelium-dependent component of beta-adrenoceptor- activated smooth muscle relaxation of mouse aorta in response to isoprenaline. J Smooth Muscle Res 2002; 38: 87-99.
16. Arribas S, Marín J, Ponte A, Balfagón G, Salaices M. Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther 1994; 270: 520-7. (Pubitemid 24271360)
17. Marín J, Balfagón G. Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors. Br J Pharmacol 1998; 124: 473-8.
18. Vanhoutte PM. Pharmacology of the blood vessel wall. J Cardiovasc Pharmacol 1981; 3: 1359-69.
19. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 2003; 55: 271-324.
20. Ayajiki K, Okamura T, Noda K, Toda N. Functional study on nitroxidergic nerve in isolated dog pulmonary arteries and veins. Jpn J Pharmacol 2002; 89: 197-200.
21. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 1999; 96: 657-62.
22. Aras-López R, Xavier FE, Ferrer M, Balfagón G. Dexamethasone decreases neuronal nitric oxide release in mesenteric arteries from hypertensive rats through decreased protein kinase C activation. Clin Sci (Lond) 2009; 117: 305-12.
23. Ferrer M, Salaices M, Balfagón G. Endogenous prostacyclin increases neuronal nitric oxide release in mesenteric artery from spontaneously hypertensive rats. Eur J Pharmacol 2004; 506: 151-6.
24. Schulz R, Nava E, Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575-80.
25. Fisher AB, Chien S, Barakat AI, Nerem RN. Endothelial cellular response to altered shear stress. Am J Physiol 2001; 281: 529-33.
26. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Kawai C. Purification of nitric oxide synthase from rat macrophages. J Biol Chem 1991: 266: 12544-7. (Pubitemid 21907128)
27. Fleming I, Gray GA, Schott C, Stoclet JC. Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol 1991; 200: 375-6.
28. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87: 10043-7.
29. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 1997; 811: 60-7.
30. Schulz R, Triggle CR. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 1994; 15: 255-9.
31. Dominiczack AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension 1995; 25: 1202-11.
32. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 1995; 57: 683-706.
33. Esplugues JV. NO as a signaling molecule in the nervous system. Br J Pharmacol 2002; 135: 1079-95.
34. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ 2003; 27: 201-6.
35. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271 (Pt 1): C1424-37.
36. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4.
37. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 2000; 20: 1430-42.
38. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 1993; 18: 195-9.
39. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
40. Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000; 190: 244-54.
41. Marín J, Rodríguez-Martínez MA. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 1997; 75: 111-34.
42. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 1996; 17: 533-85.
43. Li YJ, Dukles SP. Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur J Pharmacol 1992; 210: 23-30.
44. Wang DH, Li J. Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation. Hypertension 1999; 33 (Pt 2): 499-503.
45. Gulbenkian S, Saetrum Opgaard O, Ekman R, Costa Andrade N, Wharton J, Polak JM, et al. Peptidergic innervation of human epicardial coronary arteries. Circ Res 1993; 73: 579-88.
46. Saetrum Opgaard O, Gulbenkian S, Bergdahl A, Barroso CP, Andrade NC, Polak JM, et al. Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility. Cardiovasc Res 1995; 29: 463-8.
47. Márquez-Rodas I, Longo F, Aras-López R, Blanco-Rivero J, Diéguez E, Tejerina T, et al. Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats. Regul Pept 2006; 134: 61-6.
48. Sams-Nielsen A, Orskov C, Jansen-Olesen I. Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals. Br J Pharmacol 2001; 132: 1145-53. (Pubitemid 32238920)
49. Skofitsch G, Jacobowitz DM. Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system. Peptides 1985; 6: 721-45.
50. Angelucci F, Gruber SH, Caltagirone C, Mathé AA. Differential effects of olanzapine, haloperidol and risperidone on calcitonin gene-related peptide in the rat brain. Neuropeptides 2008; 42: 535-41.
51. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedulin. Physiol Rev 2004; 84: 903-34.
52. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54-6.
53. Balfagón G, Márquez-Rodas I, Álvarez Y, Alonso MJ, Cachofeiro V, Salaices M, et al. Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide. Regul Pept 2004; 120: 253-60.
54. Ralevic V. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed. Br J Pharmacol 2002; 137: 19-28.
55. Nuki C, Kawasaki H, Takasaki K, Wada A. Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels. J Pharmacol Exp Ther 1994; 268: 59-64. (Pubitemid 24039068)
56. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, et al. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002; 54: 233-46.
57. Prado MA, Evans-Bain B, Dickerson IM. Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 2002; 30: 460-4.
58. Kawasaki H, Inaizumi K, Nakamura A, Hobara N, Kurosaki Y. Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertens Res 2003; 26: 257-63.
59. Thota C, Gangula PR, Dong YL, Yallampalli C. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments. Biol Reprod 2003; 69: 1432-7.
60. Del Campo L, Ferrer M, Balfagón G. Hypertension alters the function of nitrergic and sensory innervation in mesenteric arteries from female rats. J Hypertens 2009; 27: 791-9.
61. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature 1990; 344: 770-3.
62. Watson RE, Supowit SC, Zhao H, Katki KA, Dipette DJ. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res 2002; 35: 1033-45. (Pubitemid 35476802)
63. Wellman GC, Quayle JM, Standen NB. ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998; 507: 117-29.
64. Shi Y, Camici GG, Lüscher TF. Cardiovascular determinants of life span. Pflugers Arch 2010; 459: 315-24.
65. Buchholz J, Sexton P, Hewitt CW. Impact of age on modulation of norepinephrine release from sympathetic nerves in the rat superior mesentery artery. Life Sci 1998; 62: 679-86.
66. Tatchum-Talom R, Martin DS. Tempol improves vascular function in the mesenteric vascular bed of senescent rats. Can J Physiol Pharmacol 2004; 82: 200-7.
67. Matz RL, Álvarez de Sotomayor M, Schott C, Andriantsitohaina R. Preservation of vascular contraction during ageing: dual effect on calcium handling and sensitization. Br J Pharmacol 2003; 138: 745-50.
68. Ferrer M, Balfagón G. Aging alters neuronal nitric oxide release from rat mesenteric arteries: role of presynaptic beta-adrenoceptors. Clin Sci (Lond) 2001; 101: 321-8.
69. Carvajal A, Velasco A, Martín-Arias LH, Maroto M. Age-related changes in contractile responses to noradrenaline in isolated blood vessels from rat and rabbit. J Auton Pharmacol 1995; 15: 321-6.
70. Li Y, Duckles SP. Effect of age on vascular content of calcitonin gene-related peptide and mesenteric vasodilator nerve activity in the rat. Eur J Pharmacol 1993; 236: 373-8. (Pubitemid 23170377)
71. Sun W, Guo J, Tang Y, Wang XJ. Alteration of capsaicin and endotoxin-induced calcitonin gene-related peptide release from mesenteric arterial bed and spinal cord slice in 18-month-old rats. J Neurosci Res 1998; 53: 385-92.
72. Dhall U, Cowen T, Haven AJ, Burnstock G. Perivascular noradrenergic and peptide-containing nerves show different patterns of changes during development and ageing in the guinea-pig. J Auton Nerv Syst 1986; 16: 109-26.
73. Mazón-Ramos P, Cordero-Fort A, Quiles-Granado J, Guindo-Soldevila J. Temas de actualidad en hipertensión arterial y diabetes. Rev Esp Cardiol 2009; 62 (Supl 1): 14-27.
74. Jackson CV, Carrier GO. Supersensitivity of isolated mesenteric arteries to noradrenaline in the long-term experimental diabetic rat. J Auton Pharmacol 1981; 1: 399-405. (Pubitemid 12185932)
75. White RE, Carrier GO. Enhanced vascular alpha-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol 1988; 255 (Pt 2): H1036-42.
76. Mueed I, Zhang L, MacLeod KM. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation. Br J Pharmacol 2005; 146: 972-82.
77. MacLeod KM. The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes. Diabetes 1985; 34: 1160-7.
78. Brondum E, Kold-Petersen H, Nilsson H, Flyvbjerg A, Aalkjaer C. Increased contractility to noradrenaline and normal endothelial function in mesenteric small arteries from the Goto-Kakizaki rat model of type 2 diabetes. J Physiol Sci 2008; 58: 333-9.
79. Ralevic V, Belai A, Burnstock G. Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur J Pharmacol 1995; 286: 193-9.
80. Ferrer M, Marín J, Balfagón G. Diabetes alters neuronal nitric oxide release from rat mesenteric arteries. Role of protein kinase C. Life Sci 2000; 66: 337-45.
81. Pamarthi MF, Rudd MA, Bukoski RD. Normal perivascular sensory dilator nerve function in arteries of Zucker diabetic fatty rats. Am J Hypertens 2002; 15 (Pt 1): 310-5.
82. Ralevic V, Belai A, Burnstock G. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin- diabetic rats. Br J Pharmacol 1993; 110: 1105-11. (Pubitemid 24005247)
83. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; Committee Hypertension. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
84. Hamilton TC. Influence of anti-hypertensive drug treatment on vascular reactivity in spontaneously hypertensive rats. Br J Pharmacol 1975; 54: 429-36.
85. Yang L, Gao YJ, Lee RM. Quinapril effects on resistance artery structure and function in hypertension. Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 444-51.
86. Laher I, Triggle CR. Pharmacological studies of smooth muscle from Dahl salt-sensitive and salt-resistant rats. Can J Physiol Pharmacol 1984; 62: 101-4. (Pubitemid 14169844)
87. Hutri-Kähönen N, Kähönen M, Wu X, Sand J, Nordback I, Taurio J, et al. Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients. Br J Pharmacol 1999; 127: 1735-43.
88. Hano T, Rho J. Norepinephrine overflow in perfused mesenteric arteries of spontaneously hypertensive rats. Hypertension 1989; 14: 44-53. (Pubitemid 19176518)
89. Tsuda K, Kimura K, Shima H, Nishio I, Masuyama Y. Presynaptic alpha 2-adrenoceptor-mediated modulation of norepinephrine release from vascular adrenergic neurons in reduced renal mass salt hypertensive rats. Clin Exp Pharmacol Physiol 1992; 19: 531-5.
90. Luo M, Fink GD, Lookingland KJ, Morris JA, Galligan JJ. Impaired function of alpha2-adrenergic autoreceptors on sympathetic nerves associated with mesenteric arteries and veins in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol 2004; 286: H1558-64.
91. Xavier FE, Salaices M, Márquez-Rodas I, Alonso MJ, Rossoni LV, Vasallo DV, et al. Neurogenic nitric oxide release increase in mesenteric arteries from ouabain hypertensive rats. J Hypertens 2004; 22: 949-57
92. Tsuda K, Tsuda S, Masuyama Y. Enhanced neuroinhibitory effect of diltiazem in blood vessels of spontaneously hypertensive rats. Am J Hypertens 1990; 3: 555-9. (Pubitemid 20383996)
93. Balt JC, Mathy MJ, Nap A, Pfaffendorf M, Van Zwieten PA. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol 2001; 38: 141-8.
94. Marín J, Ferrer M, Balfagón G. Role of protein kinase C in electrical-stimulation-induced neuronal nitric oxide release in mesenteric arteries from hypertensive rats. Clin Sci (Lond) 2000; 99: 277-83.
95. Ferrer M, Sánchez M, Minoves N, Salaices M, Balfagón G. Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneously hypertensive rats. J Vasc Res 2003; 40: 509-19.
96. Koyama T, Hatanaka Y, Jin X, Yokomizo A, Fujiwara H, Goda M, et al. Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats. Hypertens Res 2010; 33: 485-91.
97. Kawasaki H, Saito A, Takasaki K. Changes in calcitonin gene-related peptide (CGRP)-containing vasodilator nerve activity in hypertension. Brain Res 1990; 518: 303-7.
98. Kawasaki H, Saito A, Takasaki K. Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. Circ Res 1990; 67: 733-43. (Pubitemid 20315000)
99. Kawasaki H, Okazaki M, Nakatsuma A, Mimaki Y, Araki H, Gomita Y. Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats. Jpn J Pharmacol 1999; 79: 221-9.
100. Deng PY, Ye F, Zhu HQ, Cai WJ, Deng HW, Li YJ. An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats. Regul Pept 2003; 114: 175-82.
101. Márquez-Rodas I, Longo F, Rothlin RP, Balfagón G. Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 2006; 62: 45-56. (Pubitemid 44109039)
102. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.
103. Henriksen JH, Ring-Larsen H, Christensen NJ. Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis. Evidence of enhanced hepatic intestinal sympathetic nervous activity. Gut 1987; 28: 1637-42.
104. Liao JF, Yu PC, Lin HC, Lee FY, Kuo JS, Yang MC. Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats. Br J Pharmacol 1994; 111: 439-44.
105. Cawley T, Geraghty J, Osborne H, Docherty JR. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta. Br J Pharmacol 1995; 114: 791-6.
106. Vaughan RB, Angus JA, Angus PW. Vasoconstrictor responses are normal but prostanoid-mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries. J Gastroenterol Hepatol 2005; 20: 1158-64.
107. Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, et al. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension. J Hepatol 2008; 49: 43-51.
108. Wiest R, Jurzik L, Herold T, Straub RH, Schölmerich J. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension. Peptides 2007; 28: 396-404.
109. El-Sherif AM, Abou-Shady MA, Al-Bahrawy AM, Bakr RM, Hosny AM. Nitric oxide levels in chronic liver disease patients with and without oesophageal varices. Hepatol Int 2008; 2: 341-5.
110. Kwon SY, Groszmann RJ, Iwakiri Y. Increased neuronal nitric oxide synthase interaction with soluble guanylate cyclase contributes to the splanchnic arterial vasodilation in portal hypertensive rats. Hepatol Res 2007; 37: 58-67.
111. Moleda L, Jurzik L, Froh M, Gäbele E, Hellerbrand C, Straub RH, et al. Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension. World J Gastroenterol 2010; 16: 1837-44.
112. Bendtsen F, Schifter S, Henriksen JH. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol 1991; 12: 118-23.
113. Gupta S, Morgan TR, Gordan GS. Calcitonin gene-related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation? J Clin Gastroenterol 1992; 14: 122-6.
114. Hori N, Okanoue T, Sawa Y, Kashima K. Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats. J Hepatol 1997; 26: 1111-9.